Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom’s Macroglobulinemia
Given its pleiotropic functions, including its prominent role in inflammation, immune responses and cancer, the C-X-C chemokine receptor type 4 (CXCR4) has gained significant attention in recent years and has become a relevant target in drug development. Although the signaling properties of CXCR4 ha...
Main Authors: | Samantha Milanesi, Massimo Locati, Elena Monica Borroni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5696 |
Similar Items
-
Whole genome sequencing reveals that recurrent MYD88 and CXCR4 mutations underlie the genomic landscape of Waldenström's macroglobulinemia
by: Hunter, Zachary Richard
Published: (2016) -
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
by: Stefania Scala, et al.
Published: (2020-04-01) -
Macroglobulinemia de Waldenström com hemorragia intra-ocular Waldenström's macroglobulinaemia with intraocular hemorrhage
by: João J. Nassaralla Júnior, et al.
Published: (2006-12-01) -
A Rare Disease in the Differential Diagnosis of Chylothorax: Waldenström’s Macroglobulinaemia
by: İstemi Serin, et al.
Published: (2020-11-01) -
Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia
by: Lisa Marie Kaiser, et al.
Published: (2021-02-01)